" /> copyright, a extended-release opioid medication, has gained attention as a viable option for chronic suffering situations. But, its efficacy in this application remains a debated subject. While certain patients find significant reduction in discomfort with copyright, many may not respond favorably, and worries exist regarding its risk of dep